Highbridge Capital Management’s PharMerica Corporation PMC Stock Holding History

Highbridge Capital Management’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8,874	Closed	-$233K	–	1949
2017 Q2	$233K	Buy	+8,874	New	+$218K	﹤0.01%	1059
2015 Q1	–	Sell	-17,959	Closed	-$372K	–	1721
2014 Q4	$372K	Buy	17,959 +5,398	+43%	+$128K	﹤0.01%	900
2014 Q3	$306K	Sell	12,561 -2,126	-14%	-$56.4K	﹤0.01%	996
2014 Q2	$420K	Buy	+14,687	New	+$409K	0.01%	781
2014 Q1	–	Sell	-11,393	Closed	-$245K	–	1353
2013 Q4	$245K	Buy	+11,393	New	+$207K	﹤0.01%	913

Other funds holding PMC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Highbridge Capital Management's PMC Position: Q3 2017 in Review

Highbridge Capital Management sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 8,874 shares — an estimated $233K sold.

Highbridge Capital Management first reported a position in PMC in Q4 2013 and held it in 5 quarters. The position peaked at $420K in Q2 2014. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

Highbridge Capital Management reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
Highbridge Capital Management sold 8,874 PharMerica Corporation shares in Q3 2017, an estimated $233K.
Highbridge Capital Management first reported a position in PharMerica Corporation in Q4 2013 and held it in 5 quarters.
Highbridge Capital Management's PharMerica Corporation position peaked at $420K in Q2 2014.
150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on Highbridge Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.